BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25336165)

  • 1. Oral versus parenteral antimicrobials for the treatment of cellulitis: a randomized non-inferiority trial.
    Aboltins CA; Hutchinson AF; Sinnappu RN; Cresp D; Risteski C; Kathirgamanathan R; Tacey MA; Chiu H; Lim K
    J Antimicrob Chemother; 2015 Feb; 70(2):581-6. PubMed ID: 25336165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.
    Corwin P; Toop L; McGeoch G; Than M; Wynn-Thomas S; Wells JE; Dawson R; Abernethy P; Pithie A; Chambers S; Fletcher L; Richards D
    BMJ; 2005 Jan; 330(7483):129. PubMed ID: 15604157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
    Dalen D; Fry A; Campbell SG; Eppler J; Zed PJ
    Emerg Med J; 2018 Aug; 35(8):492-498. PubMed ID: 29914924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis.
    Hepburn MJ; Dooley DP; Skidmore PJ; Ellis MW; Starnes WF; Hasewinkle WC
    Arch Intern Med; 2004 Aug 9-23; 164(15):1669-74. PubMed ID: 15302637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials.
    Cooke J; Cairns CJ; Tillotson GS; Conner S; Lewin SK; Nicholls J; Tredree RL; Willis JV; Hitchings CR
    Ann Pharmacother; 1993 Jun; 27(6):785-9. PubMed ID: 8329804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind randomized controlled trial of ibuprofen compared to placebo for uncomplicated cellulitis of the upper or lower limb.
    Davis JS; Mackrow C; Binks P; Fletcher W; Dettwiller P; Marshall C; Day J; Pratt W; Tong SY
    Clin Microbiol Infect; 2017 Apr; 23(4):242-246. PubMed ID: 28274772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral flucloxacillin and phenoxymethylpenicillin versus flucloxacillin alone for the emergency department outpatient treatment of cellulitis: study protocol for a randomised controlled trial.
    Quirke M; Wakai A; Gilligan P; O'Sullivan R
    Trials; 2013 Jun; 14():164. PubMed ID: 23732051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre.
    Gouin S; Chevalier I; Gauthier M; Lamarre V
    J Paediatr Child Health; 2008 Apr; 44(4):214-8. PubMed ID: 17944880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulitis: Home Or Inpatient in Children from the Emergency Department (CHOICE): protocol for a randomised controlled trial.
    Ibrahim LF; Babl FE; Orsini F; Hopper SM; Bryant PA
    BMJ Open; 2016 Jan; 6(1):e009606. PubMed ID: 26754176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment.
    Garrett T; Harbort Y; Trebble M; Docherty T
    Emerg Med Australas; 2012 Aug; 24(4):383-92. PubMed ID: 22862755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cellulitis in a pediatric emergency department.
    Khangura S; Wallace J; Kissoon N; Kodeeswaran T
    Pediatr Emerg Care; 2007 Nov; 23(11):805-11. PubMed ID: 18007211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative only versus extended antimicrobial usage in tympanomastoid surgery: a randomized trial.
    Bidkar VG; Jalisatigi RR; Naik AS; Shanbag RD; Siddappa R; Sharma PV; Hegde HV
    Laryngoscope; 2014 Jun; 124(6):1459-63. PubMed ID: 24307502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial.
    Cranendonk DR; Opmeer BC; van Agtmael MA; Branger J; Brinkman K; Hoepelman AIM; Lauw FN; Oosterheert JJ; Pijlman AH; Sankatsing SUC; Soetekouw R; Veenstra J; de Vries PJ; Prins JM; Wiersinga WJ
    Clin Microbiol Infect; 2020 May; 26(5):606-612. PubMed ID: 31618678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT).
    Palit J; Cole J; Durojaiye OC
    Diagn Microbiol Infect Dis; 2021 May; 100(1):115305. PubMed ID: 33454560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who Can Have Parenteral Antibiotics at Home?: A Prospective Observational Study in Children with Moderate/Severe Cellulitis.
    Ibrahim LF; Hopper SM; Babl FE; Bryant PA
    Pediatr Infect Dis J; 2016 Mar; 35(3):269-74. PubMed ID: 26569189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial.
    Leman P; Mukherjee D
    Emerg Med J; 2005 May; 22(5):342-6. PubMed ID: 15843702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis.
    Quirke M; Curran EM; O'Kelly P; Moran R; Daly E; Aylward S; McElvaney G; Wakai A
    Postgrad Med J; 2018 Jan; 94(1107):25-31. PubMed ID: 28874503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML; McDonald M; Gibson K; Athan E; Munckhof WJ; Paull P; Chambers F
    Clin Infect Dis; 2002 Jun; 34(11):1440-8. PubMed ID: 12015689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
    Seaton RA; Bell E; Gourlay Y; Semple L
    J Antimicrob Chemother; 2005 May; 55(5):764-7. PubMed ID: 15772137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
    Bader MS; Twells L; Hawboldt J
    South Med J; 2011 Dec; 104(12):789-93. PubMed ID: 22089355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.